These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22372351)

  • 21. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
    Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
    Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative value of molecular forms of prostate-specific antigen in diagnosis of prostatic cancer].
    Mazo EB; Sergeeva NA; Grigor'ev ME; Lebedev DV; Solov'eva EV; Konorev VA; Krovets AA
    Urologiia; 2006; (3):21-4. PubMed ID: 16889084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A label-free immunosensor based on modified mesoporous silica for simultaneous determination of tumor markers.
    Lin J; Wei Z; Mao C
    Biosens Bioelectron; 2011 Nov; 29(1):40-5. PubMed ID: 21871790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rigorous bicycling does not increase serum levels of total and free prostate-specific antigen (PSA), the free/total PSA ratio, gonadotropin levels, or uroflowmetric parameters.
    Saka T; Sofikerim M; Demirtas A; Kulaksizoglu S; Caniklioglu M; Karacagil M
    Urology; 2009 Dec; 74(6):1325-30. PubMed ID: 19781750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liaison free PSA--an automated chemiluminescent immunoassay for the determination of free prostate specific antigen (fPSA).
    König B; Ivankovic B; Schleff R; Mack M
    Anticancer Res; 1999; 19(4A):2763-5. PubMed ID: 10470237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The application of complexed PSA and its relative indexes in the diagnosis of prostate cancer].
    Chen ZH; Zhao J; Wu JM; Xiao CG
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):36-9. PubMed ID: 12680329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
    Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
    BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical performance of the VITROS® Immunodiagnostic Products total PSA II and free PSA assays.
    De Keukeleire S; Wauters A; Luyts D; Chandler C; Piqueur M
    Clin Biochem; 2014 Sep; 47(13-14):1323-5. PubMed ID: 24940637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T; Niemela P; Haese A; Pettersson K; Erbersdobler A; Felix Chun KH; Graefen M; Kattan MW; Huland H; Lilja H
    Prostate; 2005 Apr; 63(1):13-8. PubMed ID: 15378521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parameters of PSA fractions in early diagnosis of prostatic cancer in healthy males over 50].
    Loran OB; Krokhotina LV; Pushkar' DIu; Valiev AZ; Rasner PI
    Urol Nefrol (Mosk); 1999; (1):19-21. PubMed ID: 11149339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.
    Ozdal OL; Aprikian AG; Bégin LR; Behlouli H; Tanguay S
    BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the preparation method of control samples on external quality assessment results of PSA testing.
    Bartos V; Stern P; Zavada M; Gartnarova M; Safarcik K
    Anticancer Res; 2003; 23(1A):479-84. PubMed ID: 12680253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of alpha-fetoprotein, carcinoembryonic antigen and prostate-specific antigen in serum and heparinised plasma by enzyme immunoassay on the fully automated serono SR1 analyzer.
    Cattini R; Cooksey M; Robinson D; Brett G; Bacarese-Hamilton T; Jolley N
    Eur J Clin Chem Clin Biochem; 1993 Aug; 31(8):517-24. PubMed ID: 7692986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.
    Stephan C; Cammann H; Deger S; Schrader M; Meyer HA; Miller K; Lein M; Jung K
    Urology; 2009 Oct; 74(4):873-7. PubMed ID: 19476981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer.
    Maeda H; Arai Y; Ishitoya S; Okubo K; Aoki Y; Okada T; Maekawa S
    Hinyokika Kiyo; 1998 May; 44(5):307-11. PubMed ID: 9656100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma.
    Froschermaier SE; Pilarsky CP; Wirth MP
    Urology; 1996 Apr; 47(4):525-8. PubMed ID: 8638361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
    Ulmert D; Serio AM; O'Brien MF; Becker C; Eastham JA; Scardino PT; Björk T; Berglund G; Vickers AJ; Lilja H
    J Clin Oncol; 2008 Feb; 26(6):835-41. PubMed ID: 18281654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Measurement and analysis of different serum PSA in patients with benign prostatic hyperplasia].
    Li Y; Xu P; Zhang PA; Su HW; Zhang J
    Zhonghua Nan Ke Xue; 2003 Aug; 9(5):361-3, 366. PubMed ID: 14513646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.